Ceva Animal Health Elevates Companion Animal Segment to Strategic Priority with Major Leadership Realignment

In a definitive move that signals a tectonic shift in its corporate hierarchy, Ceva Animal Health—currently the world’s fifth-largest animal health company—has announced a comprehensive strategic pivot. The organization has officially elevated its companion animal segment from a mere growth opportunity to a primary strategic pillar of its global operations. This evolution is being bolstered by the appointment of industry veteran Laura Correro as Senior Vice President of the Companion Animals franchise and the high-profile relocation of Executive Vice President Jean-Marcel Ciet to the United States.

These structural adjustments are designed to provide the agility, leadership, and geographic proximity necessary to compete aggressively within the high-stakes, multi-billion-dollar global pet care market. By anchoring executive leadership in the United States, Ceva is signaling that it is no longer satisfied with being a peripheral player in the world’s most influential veterinary market; it intends to be a dominant force.

The Strategic Shift: From Opportunity to Priority

For years, Ceva has maintained a balanced portfolio, serving livestock, poultry, and companion animals. However, the rapidly changing dynamics of the pet care industry—driven by the "humanization" of pets, the post-pandemic surge in pet ownership, and the explosion of innovative pet therapeutics—have compelled the company to re-evaluate its resource allocation.

The decision to treat companion animals as a "strategic priority" implies a multi-year commitment to R&D investment, aggressive market penetration, and potential M&A activity. Ceva recognizes that to capture market share from larger incumbents, it must optimize its internal machinery to be more responsive to the unique needs of veterinarians and pet owners alike.

Leadership Profiles and Professional Chronology

Laura Correro: The Architect of Future Growth

The appointment of Laura Correro serves as the cornerstone of Ceva’s new era. With over two decades of experience spanning both animal health and human consumer health, Correro brings a rare hybrid skill set to the role.

• The P&G Foundation (12 years): Correro’s professional trajectory began with over a decade at Procter & Gamble. Her tenure there provided her with an intimate understanding of global brand management and the intricacies of the Over-the-Counter (OTC) pharmaceutical sector—expertise that is increasingly vital as the lines between human and pet healthcare blur.
• The Boehringer Ingelheim Era: Prior to joining Ceva, Correro served as the Head of Franchises for Pet Therapeutics at Boehringer Ingelheim Animal Health. During this tenure, she oversaw global strategic marketing across veterinary channels, focusing on high-priority innovations and the development of long-term product pipelines.

In her new capacity at Ceva, Correro will define and execute the global strategy for the pet care segment, with a mandate to drive multichannel growth and strengthen the brand’s footprint in key international territories.

Jean-Marcel Ciet: The Bridge to the American Market

Simultaneously, Ceva is executing a "boots on the ground" strategy by relocating Jean-Marcel Ciet, Executive Vice President for Global Companion Animals, to Bridgewater, New Jersey. As a member of the company’s Executive Committee, Ciet’s move is not merely administrative; it is a tactical deployment. By positioning a high-level executive at the operational base of Ceva’s U.S. commercial subsidiary, the company ensures that its global strategy is filtered through the lens of local market expertise.

Supporting Data: Why the U.S. Market Matters

The decision to concentrate leadership in the United States is supported by overwhelming industry data. The North American market is, by all metrics, the epicenter of the global animal health economy.

• Market Dominance: The North American region currently accounts for more than 40% of the global pet care market value.
• The Innovation Hub: The U.S. veterinary ecosystem is the most advanced in the world, characterized by high adoption rates for new diagnostics, sophisticated pet insurance penetration, and a robust clinical research environment.
• The Trendsetter: Global trends in pet nutrition, preventative care, and chronic disease management almost exclusively originate in the United States. For a company like Ceva, being "on the ground" in New Jersey means having a front-row seat to the trends that will dictate the global industry’s direction for the next decade.

Official Responses and Executive Vision

The rhetoric coming from Ceva’s leadership underscores a company in the midst of a purposeful transformation.

Sébastien Huron, Deputy CEO of Ceva Animal Health:

"The companion animals segment is a key area of development for Ceva, and the United States plays a central role in this landscape. With these decisions, we are strengthening both our leadership and our presence in a market that is highly competitive and fast-moving. Bringing Laura on board and positioning Jean-Marcel in the U.S. reflects our intention to build our capabilities over time, step by step, to better serve our customers."

Laura Correro on her new mandate:

"I am very pleased to join Ceva at this important juncture in its development. The Companion Animals business has strong assets and excellent growth prospects. In a rapidly evolving environment, I am convinced that innovation and close collaboration with animal care stakeholders will be essential to meeting market expectations. I look forward to contributing to this ambition alongside the Ceva teams."

Jean-Marcel Ciet on the U.S. deployment:

"Laura’s appointment is a major step forward for our franchise. She brings a strong combination of strategic and commercial experience that will help us continue to build our companion animals business over time. The U.S. is the world’s leading pet care market, and our decision to anchor senior leadership on the ground there reflects how seriously we take this opportunity."

Implications: What This Means for the Industry

The implications of Ceva’s restructuring are threefold:

1. Enhanced Competitive Pressure

Ceva’s move is a direct challenge to its primary competitors. By centralizing its strategic focus and placing experienced leaders at the helm of its U.S. operations, Ceva is signaling that it intends to increase its share of the veterinary channel. Competitors can expect more aggressive marketing, faster product rollouts, and a more robust pipeline of pet therapeutics.

2. A Focus on Multichannel Distribution

Correro’s background in consumer health suggests that Ceva may seek to bridge the gap between clinical veterinary care and the retail/OTC market. As pet owners increasingly demand accessible, high-quality care, Ceva is positioning itself to be a provider that understands the entire spectrum of the pet care experience.

3. Cultural and Operational Integration

The move of Jean-Marcel Ciet to New Jersey suggests a desire to unify the "Global" and "Local" arms of the company. Often, global companies struggle with a disconnect between the headquarters’ vision and the realities of the U.S. market. By embedding executive decision-making within the local operational base, Ceva aims to minimize friction and ensure that strategic shifts are implemented with precision.

Looking Ahead: The Road to Global Leadership

As Ceva Animal Health navigates this period of internal recalibration, the industry will be watching closely to see how these leadership changes manifest in the company’s product pipeline. The goal is clear: to leverage the scale of the U.S. market to refine the company’s global value proposition.

For the veterinary community and pet owners, this realignment promises a more proactive and innovation-driven partner. For Ceva, the mission is long-term—a patient, deliberate build-out of capabilities that will cement its reputation not just as a global animal health company, but as a premier leader in the companion animal segment.

By combining top-tier executive talent with a strategic geographic pivot, Ceva has clearly signaled that it is no longer waiting for the market to dictate its growth. Instead, it is actively building the infrastructure required to shape the future of companion animal health.